NLC Health Ventures · 1 day ago
CEO for VisDX
Maximize your interview chances
BiopharmaHealth Care
Insider Connection @NLC Health Ventures
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Developing and implementing a robust business strategy, navigating the complexities of the diagnostics market, and expanding our reach across Europe and beyond.
Spearheading fundraising efforts, leveraging your investor network and securing capital to support our mission.
Overseeing day-to-day operations, ensuring high performance, regulatory compliance, and a focus on impactful results.
Driving our market positioning, working closely with our technical team to bring the product to healthcare providers, allergists, and patients.
Fostering collaborations and maintaining alignment with our partners in the medical and scientific communities to keep VisDX Allergy Solutions at the forefront of allergy diagnostics innovation.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Proven experience in the In Vitro Diagnostics (IVD) sector, ideally with a focus on allergy diagnostics.
Demonstrated success in fundraising within the diagnostics industry and an established network of investors.
Exceptional strategic and analytical skills to define and execute a scalable business model, ensuring both short- and long-term goals are met.
A high level of commitment to our mission and a clear vision of how to bring groundbreaking diagnostic solutions to market.
Ideally based in Europe.
Prior experience as a CEO or senior executive in an early-stage, venture-backed diagnostics company, with a track record of successfully navigating rapid growth phases.
Benefits
Equity-Based Remuneration
Cash Compensation
Co-Funding Opportunity
NLC Ecosystem Access
Strategic Support
Company
NLC Health Ventures
NLC Health Ventures - is dedicated to advancing health, making it accessible for everyone.
Funding
Current Stage
Growth StageTotal Funding
$6.54MKey Investors
Coöperatie VGZ
2024-06-03Corporate Round· $6.54M
2019-01-04Seed· undefined
2017-10-01Seed· undefined
Recent News
2024-06-04
2024-06-03
Company data provided by crunchbase